WBP welcomes WHAM report on investing in women’s Alzheimer’s research
A ground-breaking new report from US-based non-profit Women’s Health Access Matters (WHAM) shows that greater potential economic savings can be generated by investing in women’s Alzheimer’s research than by investing in general Alzheimer’s research.
The WHAM Report, based on research conducted by the RAND Corporation, shows that funding women’s health research isn’t just good science, it’s good investment. Doubling the current United States federal Alzheimer’s budget for women in the United States, by adding $300 million, would generate more than $930 million in economic benefits – a 224% return, the report finds.
The Women’s Brain Project CEO, Antonella Santuccione Chadha, is a member of the WHAM collaborative: “The WHAM report is a crucial piece of research that confirms the importance of considering sex and gender determinants in Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD). We would welcome the opportunity to work in partnership to expand the report with European content.”
The Women’s Brain Project is at the forefront of research into sex and gender differences in brain and mental diseases. The Swiss-based non-profit aims to establish the world’s first research for sex and gender-based precision medicine.
AD/ADRD results in substantial illness burden, health care costs, caregiving burden, and mortality. The WHAM report found that investing in women’s health research on AD/ADRD yields benefits beyond investing in general research.
To calculate the results, a representative cohort of around 1 million lives was moved through a 30-year time horizon, with the impact of investment expected ten years from initiation.
“For advocates, the WHAM Report brings fresh data and a new economic lens that makes and broadens our case,” said Meryl Comer, Vice Chair of WHAM and Co-Founder of UsAgainstAlzheimer’s. “Precision medicine starts with sex. Some of the most exciting breakthroughs in Alzheimer’s are showing us what we should already know – that sex and gender-based research is critical to finding treatments and a cure for Alzheimer’s.”